EichorEICHOR
Location: Manchester Synced from ClinicalTrials.gov · August 07, 2026

Clinical studies recruiting near Manchester

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study to Evaluate the Safety of AB-1003 (Previously LION-101) in Subjects With Genetic Confirmation of LGMD2I/R9 (Part
Phase 1/Phase 2 · AskBio Inc · NCT05230459Examining Lateralized Aspects of Motor Control Using Non-invasive Neural Stimulation
NA · Virginia Commonwealth University · NCT05947279A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Phase 3 · The Christie NHS Foundation Trust · Eli Lilly and Company · NCT07218380Symptoms and Functions in Patients With COPD and Chronic Bronchitis Switching From CIG to THS
NA · 4 Medical Clinical Solutions (4MCS) · Philip Morris Products S.A. · NCT07108166The 8x5 Diet for Bile Acid Diarrhoea: A Feasibility Randomised Controlled Trial
NA · Yvonne McKenzie · University of Manchester · NCT06259396Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
Phase 3 · Joseph Broderick, MD · NCT07227246Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN
Phase 3 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT05755386This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W
Phase 3 · The Christie NHS Foundation Trust · Pfizer · NCT07028853Enhancing Oral Cancer Awareness
NA · Virginia Commonwealth University · NCT06682494Genome Transplant Dynamics
Phase N/A · National Heart, Lung, and Blood Institute (NHLBI) · NCT02423070Randomized Trial of SGLT2i in Heart Transplant Recipients
Phase 4 · VA Office of Research and Development · NCT06625073A Global Study of Novel Agents in Paediatric and Adolescent Relapsed and Refractory B-cell Non-Hodgkin Lymphoma
Phase 2/Phase 3 · Royal Manchester Children's Hospital · University of Birmingham · NCT05991388A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line
Phase 3 · Merck Sharp & Dohme LLC · NCT06136559Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Phase 3 · Merck Sharp & Dohme LLC · NCT06393374MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Wi
Phase 2 · National Cancer Institute (NCI) · NCT05564390A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) G
Phase 1/Phase 2 · National Cancer Institute (NCI) · NCT05099003Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
Phase N/A · Galderma Investigational Site 6396 · Galderma R&D · NCT06988605Refining Adjuvant Treatment IN Endometrial Cancer Based On Molecular Features
Phase 2/Phase 3 · The NSMP-ORANGE trial: Manchester Academic Health Science Ce · Leiden University Medical Center · NCT05255653This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in
Phase 3 · The Christie NHS Foundation Trust · Pfizer · NCT06758401Study of XB010 in Subjects With Solid Tumors
Phase 1 · The Christie NHS Foundation Trust · Exelixis · NCT06545331Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma Wi
Phase 3 · Research Site · AstraZeneca · NCT07509151Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed
Phase 3 · National Cancer Institute (NCI) · NCT06172296A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes
Phase 3 · Vertex Pharmaceuticals Incorporated · NCT04786262Methods of T Cell Depletion Trial (MoTD)
Phase 2 · Manchester Royal Infirmary · University of Birmingham · NCT04888741Study of ISB 2001 in Relapsed/Refractory Multiple Myeloma (TRIgnite-1)
Phase 1 · Ichnos Sciences SA · NCT05862012Study of WAL0921 in Patients With Glomerular Kidney Diseases
Phase 2 · Manchester University NHS Foundation Trust · Walden Biosciences · NCT06466135Non-Invasive Quantification of Liver Health in NASH (N-QUAN)
NA · Perspectum · NCT04054310His-Bundle Corrective Pacing in Heart Failure
NA · University of Rochester · NCT05265520A First-in-human Dose Escalation and Expansion Study to Evaluate the Safety, and Tolerability of AZD8421 Alone or in Com
Phase 1/Phase 2 · Research Site · AstraZeneca · NCT06188520A Study to Assess the Effect of Surovatamig in Adult Participants With Antibody-mediated Kidney Disease
Phase 2 · Research Site · AstraZeneca · NCT07571746
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.